These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulation of the expression of the apolipoprotein(a) gene: evidence for a regulatory role of the 5' distal apolipoprotein(a) transcription control region enhancer in yeast artificial chromosome transgenic mice. Huby T; Afzal V; Doucet C; Lawn RM; Gong EL; Chapman MJ; Thillet J; Rubin EM Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1633-9. PubMed ID: 12842837 [TBL] [Abstract][Full Text] [Related]
3. Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet. Recalde D; Baroukh N; Viglietta C; Prince S; Verona J; Vergnes L; Pidoux J; Nazeem Nanjee M; Brites F; Ochoa A; Castro G; Zakin MM; Miller NE; Marie Houdebine L FEBS Lett; 2004 Aug; 572(1-3):294-8. PubMed ID: 15304365 [TBL] [Abstract][Full Text] [Related]
4. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Jeenah M; Kessling A; Miller N; Humphries S Mol Biol Med; 1990 Jun; 7(3):233-41. PubMed ID: 1977072 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV. Kalopissis AD; Chambaz J Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153 [TBL] [Abstract][Full Text] [Related]
7. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
10. Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study. Amos CI; Elston RC; Srinivasan SR; Wilson AF; Cresanta JL; Ward LJ; Berenson GS Genet Epidemiol; 1987; 4(2):115-28. PubMed ID: 3108069 [TBL] [Abstract][Full Text] [Related]
11. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins. Luoma PV; Marniemi J; Sotaniemi EA Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720 [TBL] [Abstract][Full Text] [Related]
12. Tissue- and developmental stage-specific expression of the rat ornithine carbamoyltransferase gene in transgenic mice. Murakami T; Takiguchi M; Inomoto T; Yamamura K; Mori M Dev Genet; 1989; 10(5):393-401. PubMed ID: 2598500 [TBL] [Abstract][Full Text] [Related]
13. Tissue specific expression of the human LCAT gene in transgenic mice and its effect on blood lipids. Mehlum A; Hagvc TA; Prydz H Z Gastroenterol; 1996 Jun; 34 Suppl 3():139-42. PubMed ID: 8767491 [No Abstract] [Full Text] [Related]